McClellan William D. Jr.

CIK 00016894022 companiesGEORGETOWN, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001689402

Recent Transactions

50 trades

Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−2,137→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−2,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−99→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−8,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−416→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−135→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−6,017→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−6,300→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−5,620→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−5,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−4,500→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−9,000→ 0 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-07-28−5,000→ 4,500 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-28$164.49/sh−5,000→ 6,017 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-07-28−5,000→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-07-28+5,000→ 11,017 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2023-07-28$26.46/sh+5,000→ 5,000 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2023-06-07+2,137→ 2,137 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2023-06-07$73.68/sh+135→ 135 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-06-07$93.61/sh+106→ 4,335 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-06-07$93.61/sh+1,682→ 6,017 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Stock Option (Right to Buy)
2023-04-04−9,848→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Stock Option (Right to Buy)
2023-04-04−19,333→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Common Stock
2023-04-04−39,249→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Non-Qualified Stock Option (right to buy)
2023-04-04−4,844→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Non-Qualified Stock Option (right to buy)
2023-04-04−5,271→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Non-Qualified Stock Option (right to buy)
2023-04-04−16,536→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Common Stock
2023-04-04−2,000→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Stock Option (Right to Buy)
2023-04-04−1,437→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Stock Option (Right to Buy)
2023-04-04−28,446→ 0 total
Award
Apollo Endosurgery, Inc.
Common Stock
2022-06-14+14,224→ 39,249 total
Award
Apollo Endosurgery, Inc.
Stock Option (Right to Buy)
2022-06-14+19,333→ 19,333 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2022-06-08$34.76/sh+287→ 346 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2022-06-08+5,620→ 5,620 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2022-06-08$34.76/sh+3,883→ 4,229 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right-to-buy)
2022-06-08$24.02/sh+416→ 416 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2022-01-03$16.14/sh+99→ 99 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2022-01-03$27.32/sh+59→ 59 total
Award
Apollo Endosurgery, Inc.
Common Stock
2021-06-17+3,888→ 25,025 total
Award
Apollo Endosurgery, Inc.
Non-Qualified Stock Option (right to buy)
2021-06-17$8.86/sh+5,271→ 66,382 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2021-06-10+5,000→ 5,000 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2020-11-12$173.21/sh−970→ 488 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2020-11-12+4,000→ 4,000 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2020-11-12−4,000→ 2,000 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2020-11-12$25.52/sh+4,000→ 4,000 total
Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2020-11-12−4,000→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2020-11-12$172.44/sh−2,542→ 1,458 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2020-11-12$174.82/sh−488→ 0 total
Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2020-11-09+4,000→ 4,000 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class B common stock
2020-11-09$26.46/sh+2,500→ 4,000 total

Companies

Recent Filings

Address

274 BUCK BEND

GEORGETOWN, TX, 78628

View on SEC.gov